UPDATE 2-FDA lets Lilly cite Jardiance heart data, shares jump

Dec 2 (Reuters) - U.S regulators said on Friday they would

allow Eli Lilly and Co to state that its diabetes drug

Jardiance reduces risk of death from heart problems, lifting

company shares almost 3...

Read more